Highlights
- BAFNAPH hit the 5% lower circuit after a sharp rally in recent sessions.
- The stock remains above its 50-day SMA despite the latest correction.
- Profit booking emerged after the share price surged to fresh highs this month.
Overview
Bafna Pharmaceuticals Limited (NSE: BAFNAPH) was locked at the 5% lower circuit at ₹165.45 on June 12, 2026. The decline follows a strong upward move that pushed the stock above ₹200 earlier in the month before witnessing a sharp pullback. While the latest correction has weighed on sentiment, the stock continues to trade above key medium-term trend levels.
Fundamental View
For the quarter ended March 2026, Bafna Pharmaceuticals reported standalone total income of INR 4,400.09 lakh. Profit before tax stood at INR 261.95 lakh, while net profit came in at INR 274.91 lakh. Earnings per share for the quarter was INR 1.16. The company remained profitable during the period, although investors may be assessing whether recent price gains had outpaced earnings expectations.
Technical View
BAFNAPH is currently trading at ₹165.45, down 5.00% in the session. Despite the lower circuit move, the stock remains above its 50-day SMA of ₹138.03, suggesting that the broader trend remains constructive. The recent rally carried the stock into overbought territory before profit booking emerged. RSI has eased to around 58 from higher levels, indicating that momentum has moderated but remains above the neutral zone. Price action suggests the stock may be entering a consolidation phase after its rapid advance.
Momentum Indicator
The RSI remains above 50, indicating that positive momentum has not completely faded despite the recent correction. However, traders may closely watch whether momentum stabilizes or weakens further in the coming sessions.
Key Technical Levels
At the current market price of ₹165.45, immediate support is placed near ₹157.20, while the next important support zone is around ₹148.90. On the upside, resistance is seen near ₹173.70, followed by a stronger hurdle around ₹181.95. The stock may require sustained buying interest above resistance levels to regain upward momentum, while a break below support could extend the consolidation.
Risks to Watch
- Profit booking after a sharp short-term rally.
- Low liquidity due to limited market participation.
- Elevated volatility under ESM surveillance.
- Sharp price swings in small-cap stocks.
Summary
BAFNAPH has witnessed a notable correction after a strong rally that attracted market attention in recent sessions. While the stock hit the lower circuit, it continues to trade above its 50-day moving average and remains in a stronger position than it was a few weeks ago. Investors may watch whether the stock stabilizes near support levels as momentum cools following the recent surge.
FAQs
- Why did BAFNAPH hit the lower circuit today?
The stock faced profit booking after a sharp rally that pushed prices to recent highs.
- Is the broader trend still positive?
The stock remains above its 50-day SMA, indicating the medium-term trend remains intact.
- What are the key levels to watch?
Support is seen near ₹157.20 and ₹148.90, while resistance is located around ₹173.70 and ₹181.95.